New pancreatic cancer pill could reshape treatment as early trial results stun researchers
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.
Videos
New pancreatic cancer pill could reshape treatment as early trial results stun researchers 5 Minuten 35 Sekunden
Ähnliche Seiten
New treatment offers hope for endometrial cancer patients
Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancer
| The Manila Times